Darin E. Olson, MD, PhD
Division of Endocrinology, Metabolism and Lipids
Emory University School of Medicine
Atlanta VA Medical Center
Stephen M. Setter, PharmD, CDE, CGP, DVM
Associate Professor of Pharmacotherapy
Washington State University
Clinical Pharmacy Consultant
Elder Services/Visiting Nurses Association
Physicians and Pharmacists: 1
Nurses and NPs: 1.2 Medium
This program was originally presented as a live audioconference series beginning in August 2005. An audio CD/workbook version is also available. If you received CME or CE credit for either the audioconference or audio CD/workbook version, you are not eligible to receive credit through this online program.
The number of Americans age 65 and over is expected to increase by 34% over the next two decades. In this age demographic, diabetes continues to increase, with nearly 1 out of every 5 persons age 60 and over currently diagnosed with diabetes. Clearly, as the population continues to age and diabetes prevalence increases, it is important for healthcare professionals in the long-term care setting to respond appropriately to diabetes among these older adults. This continuing education program will review and discuss advances in medical knowledge about effective treatments for this population.
Through presentation of case studies, our expert faculty will discuss the latest diabetes treatment guidelines—including recent recommendations from the American Geriatric Society and the American Diabetes Association guidelines updated in January 2005. The program will emphasize the importance of establishing individualized treatment goals and how the treatment of diabetes in older adults differs from that in younger populations.
. Target Audience
Healthcare professionals on the geriatric healthcare team: long-term care medical directors, consultant and V.A. pharmacists, directors of nursing, nurse practitioners, and nurses in long-term care.
Upon completion of this educational activity, the participant should be able to:
Develop pharmacological and non-pharmacological treatment recommendations for the management of diabetes in the older adult with multiple comorbidities.
Evaluate current guidelines and treatment recommendations for older adults with diabetes.
Review the relationship between cardiovascular disease and diabetes in older adults.
Review currently available hypoglycemic oral agents and insulins.
AKH Inc. and its shareholders have no significant financial relationships with the manufacturers of medical or pharmaceutical products, nor with the providers of non-educational medical services. It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in the monograph or with the commercial supporter of this continuing education activity. The information is for participant information only; it is not assumed that these relationships will have a negative impact on the content of the activity.
Darin E. Olson, MD has no commercial interests to disclose.
Stephen Setter, PharmD, CDE, CGP, DVM discloses that he is a member of a speakers bureau for sanofi-aventis.
This educational activity may contain discussion of published and/or investigational uses of agents for the treatment of diabetes. Some uses of these agents may not been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this educational activity for a maximum of 1 category 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
This program (ACPE# 203-999-05-046-H01) was developed by the American Society of Consultant Pharmacists (ASCP) and is approved for 1.0 Contact Hour (0.1 CEU). ASCP is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
AKH Inc. is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. Provider #030803. AKH Inc. designates this educational activity for 1.2 contact hour(s).
This program has been approved for 1.2 contact hours by NADONA/LTC. NADONA/LTC (OH-168, 10-05) is an approved provider of continuing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (OBN-001-91).
Release Date: August 18, 2005 Credit Expiration Date: November 30, 2006
Credit will be awarded upon submission of a completed program evaluation and a post-test with a passing grade of 70% or better.
AAPA accepts Category I CME credit for the PRA from organizations accredited by ACCME. All programs on cmecorner.com which carry ACCME Category I CME credit are acceptable towards the PA Category I (Preapproved) CME requirement.
Commercial Support Statements
Supported by an educational grant from GlaxoSmithKline.
Click on the "Start program" icon.
The next screen will permit you to check for or download the Flash player required to run this program.
Clicking on "start the program" on this screen will bring you to instructions to turn off pop-up blockers and allow you to begin the program presentation which will take approximately 60 minutes to complete.
Upon completion of the program, click on the post-test button to register and access the post-test and program evaluation.
Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a CME/CE certificate.
None of the contents may be reproduced in any form without prior written permission of the publisher. The opinions expressed in this publication and audioconference are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., the American Society of Consultant Pharmacists, the National Association of Directors of Nursing Administration in Long-Term Care or GlaxoSmithKline. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and of possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.